1.Effects of LOX-1 gene G501C variation on brain structural changes and cognitive function in patients with white matter hyperintensities
Yajun ZHOU ; Shujian CHEN ; Zhixin WANG ; Yayu WANG ; Chaojuan HUANG ; Xia ZHOU ; Xiaoqun ZHU
Acta Universitatis Medicinalis Anhui 2026;61(3):562-568
ObjectiveTo investigate the effects of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) gene G501C on brain structure and cognitive function in patients with white matter hyperintensities (WMH). MethodsA total of 118 patients with WMH were enrolled. All participants underwent T1-weighted and T2-fluid-attenuated inversion recovery (T2-FLAIR) MRI to assess gray matter structure and WMH burden, and completed the mini-mental state examination (MMSE) and Montreal cognitive assessment (MoCA). Partial correlation and mediation analyses were performed to explore the impact of LOX-1 polymorphism on cognitive function. ResultsParticipants were divided into GG+GC group (n = 35) and CC group (n = 83). The GG+GC group showed lower MMSE and MoCA scores (MMSE: P=0.003; MOCA: P=0.015), as well as greater WMH burden (all P0.001), compared with the CC group. Voxel-based morphometry (VBM) analysis revealed reduced left thalamic volume in the GG+GC group, which was correlated with cognitive scores (all P0.05). Subregional thalamic analysis further showed volume reductions in the lateral, ventral, medial, and pulvinar thalamic regions (all P0.05) in the GG+GC group, all positively associated with cognitive performance (all P0.05). Mediation analyses indicated that volumes of the medial and pulvinar thalamic regions mediated the association between genotype and cognitive function (MMSE, MoCA), and that WMH volume mediated the effect on MoCA scores. ConclusionThe LOX-1 G501C polymorphism may indirectly affect cognitive function by influencing specific thalamic subregional volumes and white matter damage, suggesting a potential mediating role of thalamic structures between genetic background and cognitive impairment.
2.Effects of different antiplatelet therapy regimens on cognitive function and brain imaging biomarkers in patients with cerebral small vessel disease
Zhixin WANG ; Yuehua WANG ; Jiajia QIN ; Xiaohan SONG ; Xia ZHOU ; Xiaoqun ZHU
Acta Universitatis Medicinalis Anhui 2026;61(9):1679-1687
ObjectiveTo investigate the effects of different antiplatelet therapy regimens (aspirin versus clopidogrel at specific doses) on cognitive function, blood biomarkers and brain imaging biomarkers when used prophylactically in patients with cerebral small vessel disease (CSVD). MethodsA randomized controlled trial was conducted involving 160 CSVD patients who were randomly assigned to four groups: aspirin group (ASA), low-dose clopidogrel group (CLOP-50), standard-dose clopidogrel group (CLOP-75), and control group (HC). Cognitive function [auditory verbal learning test-immediate recall (AVLT-IR), auditory verbal learning test-short-delay recall (AVLT-SDR), auditory verbal learning test-long-delay recall (AVLT-LDR), hamilton anxiety rating scale (HAMA), and hamilton depression rating scale (HAMD), ADL(activities of daily living scale ), (ascertain dementia 8-item questionnaire,AD8)], blood biomarkers [platelet count (PLT) and mean platelet volume (MPV)], and CSVD-related imaging biomarkers [white matter hyperintensities (WMH) and cerebral microbleeds (CMB)] were assessed in all groups at baseline and at the 6-month follow-up. ResultsAfter 6 months of treatment, within-group comparisons showed that, compared with baseline, the ASA group had significantly increased scores on the AVLT immediate recall (AVLT-IR), short-delay recall (AVLT-SDR), and long-delay recall (AVLT-LDR) (P<0.05). The CLOP-75 group showed significantly decreased HAMA and HAMD scores (P<0.05), along with a significant increase in AVLT-LDR scores (P<0.05). The number of CMBs increased from baseline in both the ASA and CLOP-75 groups (P<0.05), whereas no statistically significant changes in blood biomarkers were observed in either group. By contrast, the CLOP-50 and HC groups showed no significant changes in cognitive function, blood biomarkers, or CSVD-related imaging biomarkers compared with baseline (all P<0.05). Comparisons between groups showed that the AVLT-LDR scores and the number of CMBs increased faster in the ASA group than in the HC group (β=-0.187, P=0.04; β=-0.805, P<0.001). In addition, the rate of CMB increase was also faster in the ASA group than in the CLOP-50 group (β=-0.695, P<0.01). The ADL scores increased faster in the HC group than in the ASA group (β=0.170, P=0.02). The AD8 scores decreased faster in the CLOP-75 group than in the HC group (β=-0.128, P=0.04), but the rate of CMB increase in the CLOP-75 group was also faster than that in the HC group (β=0.604, P=0.04). ConclusionIn CSVD patients, aspirin 100 mg or clopidogrel 75 mg improves cognitive function but increases the risk of cerebral hemorrhage. Clopidogrel 50 mg shows no short-term clinical benefit or imaging improvement.
3.Exploration on quality evaluation indicators and technical requirements for national mutual recognition of clinical laboratory results
Jiali LIU ; Wei WANG ; Yuxuan DU ; Zhixin ZHANG ; Zhiguo WANG
Chinese Journal of Laboratory Medicine 2025;48(5):563-567
National mutual recognition of clinical laboratory test results is an important measure to improve the utilization of medical resources and reduce the economic burden of healthcare for the public. The essence of mutual recognition of test results is to ensure that the test results between different medical institutions are consistent and comparable, thereby avoiding duplicate testing and waste of medical resources, and improving the patient′s healthcare experience. The evaluation of comparability of inspection results, quality measurement and monitoring of mutual recognition laboratories and tests, as well as the development of quality evaluation indicators and technical requirements for mutual recognition laboratories, are the core issues for the realization of mutual recognition of inspection results nationwide. This article explores the quality evaluation indicators and technical requirements for mutual recognition of clinical laboratory test results nationwide to speed up this process.
4.Screening prognosis-related genes and predictive model constructing for lung adenocarcinoma
Zhixin ZHANG ; Lei FU ; Mengxue WANG ; Yi ZOU ; Liyan WEN ; Bo XIAO
China Modern Doctor 2025;63(14):1-5
Objective To explore the prognosis-related genes of lung adenocarcinoma(LUAD)and establish a prognostic prediction model for LUAD.Methods The differentially expressed genes of LUAD tissues and adjacent normal tissues in the GSE43458,GSE7670,and GSE140797 datasets were screened.The protein-protein interaction(PPI)network analysis,gene ontology(GO)function,Kyoto Encyclopedia of Genes and Genomes(KEGG)signaling pathway enrichment analyses,least absolute shrinkage and selection operator for prognosis coefficient screening,disease-specific survival analysis,Cox regression analysis,and gene correlation analysis were performed.Independent prognostic genes of LUAD were screened from the differential genes,and a prognostic prediction model of LUAD was established.The expression of independent prognostic genes was analyzed,and the predictive model was evaluated by receiver operating characteristic(ROC)curve.The GSE68465 data set was used as an external validation set to verify the predictive model.Results There were 197 up-regulated differential genes and 77 down-regulated differential genes in LUAD and adjacent normal tissues common to the three datasets.Through stepwise screening,two genes,IL7R and SLC2A1,were identified as independent prognostic factors for LUAD.IL7R was an independent protective factor,while the SLC2A1 was an independent risk factor.A prediction model for curve was built with IL7R and SLC2A1.The prediction model for LUAD constructed with IL7R and SLC2A1 is as follows:Risk score=(-0.694)×expression level of IL7R+0.763×expression level of SLC2A1.Conclusion This study screened out IL7R as an independent prognostic protective factor for LUDA,and SLC2A1 as an independent prognostic risk factor for LUAD.The LUDA prediction model constructed based on these two genes has good predictive ability and generalization ability,which can provide references for the research and clinical individualized treatment of LUAD.
5.The application value of serum heat shock protein 70,Periostin combined with low-dose spiral CT in early diagnosis of lung cancer
Shaohua WANG ; Chunrong WANG ; Xiaoyan HUANG ; Yongbin LIU ; Zhixin LIU
Journal of Clinical Surgery 2025;33(10):1069-1072
Objective To explore the early diagnostic value of serum heat shock protein 70(HSP70),periosten combined with low-dose spiral CT(LDCT)for lung cancer.Methods From July 2022 to June 2024,103 lung cancer patients admitted to our hospital were regarded as the lung cancer group,and 87 patients with benign pulmonary nodules were selected as the benign group.ELISA kit was used to measure serum HSP70 and Periostin.Multivariate logistic regression was applied to analyze the influencing factors of lung cancer.Four grid table method was applied to calculate the sensitivity,specificity,and accuracy of LDCT combined with serum HSP70 and Periostin in the diagnosis of lung cancer.Kappa test was applied to evaluate the consistency between LDCT,serum HSP70,Periostin combined with LDCT and pathological diagnosis of lung cancer.Results Compared with the benign group,the lung cancer group had greatly higher levels of serum HSP70 and Periostin(P<0.05).Compared to the benign group,the lung cancer group had higher proportions of lobulation and spiculation signs(P<0.05).Multivariate logistic regression showed that HSP70(OR=1.569),Periostin(OR=1.427),lobulation sign(OR=2.015),and spiculation sign(OR=1.946)were all independent risk factors for lung cancer(P<0.05).The sensitivity,specificity,and accuracy of LDCT in diagnosing lung cancer were 85.44%,88.51%,and 86.84%,respectively;the sensitivity,specificity,and accuracy of serum HSP70 and Periostin combined with LDCT in diagnosing lung cancer were 93.20%,80.46%,and 87.37%,respectively.Kappa test showed that the consistency between serum HSP70,Periostin combined with LDCT had high consistency with pathology in the diagnosis of lung cancer(Kappa value=0.743).Conclusion The serum levels of HSP70 and Periostin are higher in lung cancer patients.The combination of serum HSP70 and Periostin with LDCT has better diagnostic efficacy for lung cancer.
6.Research on challenges and recommendations for application of artificial intelligence in Immunology education
Enning ZHANG ; Chen WANG ; Zhixin ZHENG ; Chonghao ZHANG ; Yu HAO ; Guiying PENG
Chinese Journal of Immunology 2025;41(6):1290-1293
Intricate nature of Immunology teaching,characterized by diverse cellular types,complex molecular mechanisms,and highly dynamic immune responses,poses significant challenges.Utilization of artificial intelligence(AI)technology to provide personalized learning pathways and resources for Immunology education has emerged as a critical direction in contemporary educational reform.By examining current domestic application status and specific teaching practices,this article explores gap between AI technology and traditional teaching theories,analyzes issues such as deep integration and transformation of teacher's role.Special attention is also given to ethical considerations,including privacy protection,fairness and accessibility,and ethical implications of data processing.In response to these issues,authors propose a set of comprehensive recommendations,including establishing a student-centered learning model,strengthening teaching staff capabilities,improving privacy protection and algorithmic transparency,promoting educational equity,and reinforcing ethical education,aiming to support healthy and sustainable development of AI technology within Immunology education,offering valuable insights for reform and innovation of Immunology education.
7.The application value of serum heat shock protein 70,Periostin combined with low-dose spiral CT in early diagnosis of lung cancer
Shaohua WANG ; Chunrong WANG ; Xiaoyan HUANG ; Yongbin LIU ; Zhixin LIU
Journal of Clinical Surgery 2025;33(10):1069-1072
Objective To explore the early diagnostic value of serum heat shock protein 70(HSP70),periosten combined with low-dose spiral CT(LDCT)for lung cancer.Methods From July 2022 to June 2024,103 lung cancer patients admitted to our hospital were regarded as the lung cancer group,and 87 patients with benign pulmonary nodules were selected as the benign group.ELISA kit was used to measure serum HSP70 and Periostin.Multivariate logistic regression was applied to analyze the influencing factors of lung cancer.Four grid table method was applied to calculate the sensitivity,specificity,and accuracy of LDCT combined with serum HSP70 and Periostin in the diagnosis of lung cancer.Kappa test was applied to evaluate the consistency between LDCT,serum HSP70,Periostin combined with LDCT and pathological diagnosis of lung cancer.Results Compared with the benign group,the lung cancer group had greatly higher levels of serum HSP70 and Periostin(P<0.05).Compared to the benign group,the lung cancer group had higher proportions of lobulation and spiculation signs(P<0.05).Multivariate logistic regression showed that HSP70(OR=1.569),Periostin(OR=1.427),lobulation sign(OR=2.015),and spiculation sign(OR=1.946)were all independent risk factors for lung cancer(P<0.05).The sensitivity,specificity,and accuracy of LDCT in diagnosing lung cancer were 85.44%,88.51%,and 86.84%,respectively;the sensitivity,specificity,and accuracy of serum HSP70 and Periostin combined with LDCT in diagnosing lung cancer were 93.20%,80.46%,and 87.37%,respectively.Kappa test showed that the consistency between serum HSP70,Periostin combined with LDCT had high consistency with pathology in the diagnosis of lung cancer(Kappa value=0.743).Conclusion The serum levels of HSP70 and Periostin are higher in lung cancer patients.The combination of serum HSP70 and Periostin with LDCT has better diagnostic efficacy for lung cancer.
8.Construction of p97 mutant of Mesomycoplasma hyopneumoniae based on the homologous recombination system
Yanna WEI ; Jiying WANG ; Huan XIE ; Zhiqiang LI ; Z.A.Ishag HASSAN ; Xing XIE ; Bin XU ; Qiyan XIONG ; Zhixin FENG ; Guoqing SHAO ; Yanfei YU
Chinese Journal of Veterinary Science 2025;45(3):473-481
The aim of this study is to establish an gene editing method of Mesomycoplasma hyo-pneumoniae(Mhp)based on the homologous recombination principle.The restriction enzyme di-gestion and ligation method combined with gene synthesis were used to construct a shuttle plasmid to achieve replication in both Mhp and Escherichia coli(E.coli).The pGEM?-T vector was used as the skeleton.The oriC sequence of Mhp which can achieve the replication of the plasmid in Mhp was inserted into the vector.Sequences of the Spiroplasma promoter and puromycin resistance gene were then inserted into the above constructed plasmid to screen recombinant clones.The up-stream and downstream homologous arms of p97 were constructed to initiate homologous recombination.The recA gene of E.coli is inserted to improve the efficiency of homologous recom-bination.The obtained shuttle plasmid was then delivered into Mhp by electro-transformation or chemical transformation.A shuttle plasmid,pGEM?-Mhp-oriC-p 97,which can replicate in both Mhp and E.coli was constructed.With the transformation of this plasmid,the carried puromycin gene and recA gene can be expressed,the p97 gene can be edited.Finally,the genetically unstable p97 gene mutant was initially obtained.In this study,a tool for Mhp gene editing based on the principle of homologous recombination was established,which laid a foundation for the develop-ment of tools for studying the pathogenesis of Mhp.
9.Associations of demographics, aggravating factors, comorbidities, and treatments with atopic dermatitis severity in China: A national cross-sectional study
Jiahui ZHAO ; Zhixin ZHANG ; Hongguang CHEN ; Xia DOU ; Zuotao ZHAO ; Lingling LIU ; Yang WANG ; Hang LI
Chinese Medical Journal 2025;138(5):553-561
Background::Atopic dermatitis (AD) is a chronic inflammatory skin disorder impacting populations worldwide, although its clinical characteristics and patient demographics remain uncharacterized in China. The aim of this study was to investigate the demographics, comorbidities, aggravating factors, and treatments in AD patients across different age groups in China.Methods::This cross-sectional study included Chinese AD patients from 205 hospitals spanning 30 provinces. Patients completed dermatologist-led surveys of general medical history, comorbidities, AD-related aggravating factors, and medications. Two-level mixed-ordered logistic regression was used to evaluate aggravating factors.Results::Overall, 16,838 respondents were included in the final analysis (aged 30.9 ± 24.1 years). The proportion of severe AD was the highest in patients with AD onset at ≥60 years (26.73%). Allergic rhinitis and hypertension were the most common atopic and metabolism-related non-atopic comorbidities, respectively. AD severity was significantly associated with chronic urticaria, food allergies, and diabetes. Aggravating factors including foods, seasonal changes, and psychological factors were also linked to AD severity. The cross-sectional survey implied that severe AD may be related to the undertreatment of effective systemic or topical interventions.Conclusion::To enhance the management of AD, it is crucial to consider both aggravating factors and the increased utilization of systemic immunotherapy.Registration::ClinicalTrials.gov, NCT05316805
10.In vitro study of ultrasound/near-infrared bimodal responsive quantum dots nanomolecular probes for microthrombosis diagnosis and treatment
Zhixin JIANG ; Nan JIANG ; Zhiwen WANG ; Mengying SUN ; Bin GUI ; Zhiquan TIAN ; Bo HU
Chinese Journal of Nuclear Medicine and Molecular Imaging 2025;45(1):29-34
Objective:To evaluate the application potential of the bimodal ultrasound/near-infrared (NIR) composite nanoscale probe Arg-Gly-Asp (RGD)/Ag 2Te/perfluoropentane (PFP) @ mesoporous silica nanoparticles (MSN) in the diagnosis and treatment of microvascular diseases. Methods:Nanoprobes loaded with RGD, PFP and Ag 2Te were prepared by ultrasound sonication and carbodiimide method. The characterization of the nanoprobes was determined. The imaging performance, photothermal response, and target-seeking ability of the nanoprobes under NIR irradiation were verified. The biosafety of the nanoprobes was examined, and the thrombolytic ability of the nanoprobes was evaluated. The mice were observed to visualize microvessels of the abdominal wall under the NIR-Ⅱ imaging, and the microvascular visualization ability of the nanoprobes was evaluated. Results:The particle size of nanoprobes was (205.3±2.9) nm and the potential was (2.05±0.58) mV. The coupling rate of the RGD was (82.27±0.36)%, the encapsulation rate of the quantum dots was (80.80±3.26)%, and the photostability of the quantum dots was good. The fluorescence intensity was enhanced with the increase of the mass concentration of RGD/Ag 2Te/PFP@MSN, and the warming effect was more obvious. After ultrasound and NIR irradiation, the thrombolysis rate was significantly increased. RGD/Ag 2Te/PFP@MSN successfully realized NIR-Ⅱ fluorescence imaging of mice microvessels. The cytotoxicity assay and hemolysis assay showed that the probe had a good biosafety. Conclusion:The RGD/Ag 2Te/PFP@MSN nanoprobe is a potential strategy for targeted therapy of thrombotic diseases, combining dual-modality therapy of ultrasound and NIR to offer new possibilities for non-invasive and visual diagnosis and treatment of microvascular embolism.

Result Analysis
Print
Save
E-mail